Hydroxychloroquine: Dangerous drug or innocent victim?
by James Todaro, MD
LATEST COVID-19 STUDIES
Henry Ford Hospital study shows HCQ may reduce mortality over 50% in early hospital use
Zelenko et al publishes study of outpatient HCQ use with 99.3% outpatient survival rate
Raoult et al reports only 0.5% mortality rate in 3,737 COVID-19 patients treated with HCQ+AZ
NEJM study on hydroxychloroquine for post-exposure prophylaxis shows no benefit and no harm
Hydroxychloroquine increases survival in EARLY treatment of COVID-19 (FJ Membrillo, et al)
HCQ + AZ reduces transfer to ICU and death compared to standard therapy...p=0.002 (B Davido, et al)
Early treatment of COVID-19 with HCQ and AZ results in 98.7% cure rate in study of 1061 cases in France (D Raoult, et al)
Remdesivir WITHOUT clinical benefit in randomized placebo-controlled trial (Y Wang, et al)
Prospective study at Prevent Senior Institute in São Paulo, Brazil shows EARLY outpatient treatment with HCQ + AZ results in DECREASED need for hospitalization (RB Esper, et al)
VA study shows treatment of LATE STAGE COVID-19 with HCQ + AZ is not effective (J Magagnoli, et al)
CENSORED BY GOOGLE The original google doc on "An Effective Treatment for Coronavirus" by Todaro and Rigano (since taken down by Google in March 2020)
Archived studies and reports on HCQ/AZ/Zinc in treatment of COVID-19 and antibody prevalence studies can be found in the following Google Doc curated by JM Todaro, MD.
NEWS
Twenty-one billion reasons to discredit hydroxychloroquine
A Study Out of Thin Air (MedicineUncensored original article) leads to retraction of Lancet study
LANCET STUDY RETRACTED...in just 13 days
WHO coincidentally resumes clinical trials on HCQ right as #LancetGate hits mainstream news
The Guardian publishes scathing investigative report on Surgisphere, referencing MedicineUncensored!
Lancet now publishes its own Expression of Concern over the Surgisphere study!
NEJM publishes "Substantive concerns" with Surgisphere database...Is retraction next?
CDC report confirms estimates of low fatality and hospitalization rates of COVID-19...IFR ~0.3%
Media no longer interested in Florida after underwhelming death counts weeks after reopening
News of “ICUs full of healthy young people” exaggerated morbidity fears...If infected with COVID-19, actual risk of needing any hospitalization is only 0.9% for New Yorkers between 18 and 44 years of age
IVERMECTIN results in complete recovery from COVID-19 in under 4 days in trial of 60 patients
Outbreaks in meat plants imply workforce infection fatality rate is 0.2%!
Trump threatens to permanently pull funding from World Health Organization
NIH begins enrollment in national trial of HCQ + AZ for COVID-19, including PREGNANT WOMEN
Government lockdown in Spain results in HIGHER infection rates in those over age 60 who stayed home!
Seasonal flu/pneumonia results in more life-years lost than COVID-19 during same period in 2020
PayPal mafia's Keith Rabois discusses Trump Derangement Syndrome surrounding HYDROXYCHLOROQUINE
Top critic of Didier Raoult cited in New York Times feature linked to Gilead and Remdesivir!
Raoult exposes 3 critical biases in infamous VA study of hydroxychloroquine
Elon Musk content on COVID-19 censored by Google yet again!
VIDEOS
CENSORED: America's Frontline Doctors Press Conference at the Supreme Court
"Twenty-one billion reasons to discredit hydroxychloroquine"
CENSORED BY YOUTUBE Bakersfield doctors hold a press conference challenging California's stay-at-home order
CENSORED BY YOUTUBE
Professor Dr. Karol Sikora speaks about COVID-19 antibody tests, immunity in the young and possibility that the virus may be burning out naturally
Tips or news stories? Please email
James Todaro, MD received his medical degree from Columbia University, Vagelos College of Physicians and Surgeons in NY, and completed his surgical training with four additional years of residency in ophthalmology.
A long-time advocate of free speech, Dr. Todaro has doggedly pursued the dissemination of vital medical knowledge and evidence during the COVID-19 pandemic, despite censorship by social media platforms and ad hominem attacks by mainstream media outlets.
On March 13, 2020, Dr. Todaro and Gregory Rigano, Esq published the first widely disseminated paper proposing chloroquine and hydroxychloroquine in treatment of COVID-19. The publication was later taken down by Google despite triggering widespread use and ongoing clinical investigation of the drug's effectiveness in over 100 clinical trials.